openPR Logo
Press release

Peptide Synthesis Market Expected to Reach USD 2,175.91 Million by 2034, Growing at a CAGR of 12.4%

05-08-2025 08:28 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Peptide Synthesis Market

Peptide Synthesis Market

The peptide synthesis market is expected to gain market growth during the forecast period of 2025 to 2034. Polaris Market Research analyses the market to account for USD 2,175.91 million by 2034 and is expected to register a CAGR of 12.4% in the above-mentioned forecast period. The market was valued at USD 679.93 million in 2024.

Market Definition
A peptide comprises two or more amino acids connected by an amide bond to configure a chain of amino acids coupling agents normally 2-70 amino acids long. Peptides are differentiated by proteins by not needing to be folded for biological tasks. They are synthesized chemically either in solution or in the solid stage. This procedure includes administering and choosing the configuration of an amide bond between N-safeguarded amino acids and an amino acid carrying a free amino group and safeguarded carboxylic acid.
Peptide synthesis is utilized in preventive medicines.

Antibody production services and antibody sequencing services are two important factors of preventive medicines. Subsequently, commercial peptide synthesis firms offer services to research facilities and the vaccine industry. Also, drug detection of the biopharmaceutical applications of peptides capitalizes on a peptide's cellular operations to cure illnesses.

Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/peptide-synthesis-market/request-for-sample

Competitive Landscape
The market is competitive with the presence of several leading players. Key companies are mentioned below:
• Bachem Holding AG
• Biotage
• Creative Diagnostics
• GenScript
• Lonza
• Merck KGaA
• PolyPeptide Group
• Puresynth Research Chemicals Pvt Ltd.
• Syngene International Limited
• Thermo Fisher Scientific Inc.

Peptide Synthesis Market Report Highlights
• In terms of application, the therapeutics segment led the market in 2024, driven by the growing use of peptide-based drugs for treating diseases such as cancer, metabolic disorders, and autoimmune conditions.

• Based on technology, the hybrid technology segment is anticipated to experience the fastest market growth as it integrates the benefits of both solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS).

• North America accounted for the largest share of peptide synthesis market in 2024, supported by significant investments in pharmaceutical and biotechnology research and the presence of major peptide drug manufacturers and research institutions.

• Asia Pacific is expected to see the fastest growth during the forecast period, fueled by increasing biotechnology investments, expanding pharmaceutical manufacturing capabilities, and rising demand for peptide-based therapeutics.

Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/peptide-synthesis-market/request-for-discount-pricing

Market Growth Drivers and Opportunities
Growing Demand for Peptide-Based Therapeutics: Therapeutic peptides provide precision, productivity, and lesser harm compared to conventional small molecules, making them suitable for curing several illnesses, such as metabolic illnesses, cancer, and infectious illnesses. Thus, peptides have surfaced as an important constituent in contemporary drug advancements thus propelling the peptide synthesis market forward.

Expanding Applications: The augmenting applications of peptide synthesis in diagnostics and imaging assist in market advancement by enhancing illness detection and observation. Peptides are extensively utilized in biomarker recognition, molecular imaging, and earmarked contrast agents because of their superior binding harmony and precision. Their contribution in diagnostic assays, immunoassays and radiolabeled peptides for imaging methodologies has profoundly enhanced the preciseness and productivity of disease detection.

Segmental Analysis
Global Peptide Synthesis Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. Global Peptide Synthesis Market, by Product, 2020-2034 (USD million)
5.3. Equipment
5.3.1. Global Peptide Synthesis Market, by Equipment, by Region, 2020-2034 (USD million)
5.4. Reagents & Consumable
5.4.1. Global Peptide Synthesis Market, by Reagents & Consumable, by Region, 2020-2034 (USD million)
5.5. Services
5.5.1. Global Peptide Synthesis Market, by Drug Discovery Services, by Region, 2020-2034 (USD million)

Global Peptide Synthesis Market, by Technology
6.1. Key Findings
6.2. Introduction
6.2.1. Global Peptide Synthesis Market, by Technology, 2020-2034 (USD million)
6.3. Solid Phase Peptide Synthesis (SPPS)
6.3.1. Global Peptide Synthesis Market, by Solid Phase Peptide Synthesis (SPPS), by Region, 2020-2034 (USD million)
6.4. Liquid Phase Peptide Synthesis (LPPS)
6.4.1. Global Peptide Synthesis Market, by Liquid Phase Peptide Synthesis (LPPS), by Region, 2020-2034 (USD million)
6.5. Hybrid Technology
6.5.1. Global Peptide Synthesis Market, by Hybrid Technology, by Region, 2020-2034 (USD million)

Global Peptide Synthesis Market, by Application
7.1. Key Findings
7.2. Introduction
7.2.1. Global Peptide Synthesis Market, by Therapeutics, 2020-2034 (USD million)
7.3. Therapeutics
7.3.1. Global Peptide Synthesis Market, by Commercial, by Region, 2020-2034 (USD million)
7.4. Diagnosis
7.4.1. Global Peptide Synthesis Market, by Diagnosis, by Region, 2020-2034 (USD million)
7.5. Research
7.5.1. Global Peptide Synthesis Market, by Research, by Region, 2020-2034 (USD million)

Global Peptide Synthesis Market, by End Use
8.1. Key Findings
8.2. Introduction
8.2.1. Global Peptide Synthesis Market, by End Use, 2020-2034 (USD million)
8.3. Academic & Research Institutes
8.3.1. Global Peptide Synthesis Market, by Academic & Research Institutes, by Region, 2020-2034 (USD million)
8.4. Contract Development & Manufacturing Organization/Contract Research Organization
8.4.1. Global Peptide Synthesis Market, by Contract Development & Manufacturing Organization/Contract Research Organization, by Region, 2020-2034 (USD million)
8.5. Academic & Research Institutes
8.5.1. Global Peptide Synthesis Market, by Academic & Research Institutes, by Region, 2020-2034 (USD million)

Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/peptide-synthesis-market

Geographical Outlook
Geographically, the market is analyzed across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America dominated the market in 2024 due to robust funding in pharmaceutical and biotechnology research, along with the existence of foremost peptide drug manufacturers and research bodies.

Asia Pacific is witnessing the fastest growth in the peptide synthesis market due to growing funding in biotechnology, augmenting pharmaceutical manufacturing potential, and growing demand for peptide-dependent drugs.

More Trending Latest Reports by Polaris Market Research:
Synoptophore Market
https://www.polarismarketresearch.com/industry-analysis/synoptophore-market

Hereditary Testing Market
https://www.polarismarketresearch.com/industry-analysis/hereditary-testing-market

Microcarriers Market
https://www.polarismarketresearch.com/industry-analysis/microcarriers-market

Forensic Imaging Market
https://www.polarismarketresearch.com/industry-analysis/forensic-imaging-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptide Synthesis Market Expected to Reach USD 2,175.91 Million by 2034, Growing at a CAGR of 12.4% here

News-ID: 4004844 • Views:

More Releases from Polaris Market Research & Consulting

Mobile Biometrics Market is projected to reach USD 271.62 Billion by 2034, expanding at a strong CAGR of 19.88% during the forecast period from 2026 to 2034.
Mobile Biometrics Market is projected to reach USD 271.62 Billion by 2034, expan …
The global mobile biometrics market is projected to be valued at approximately USD 53.10 billion in 2025 and is expected to witness strong growth through 2034, driven by rising concerns over data security, increasing smartphone-based digital transactions, and the growing adoption of biometric authentication across banking, enterprise, and government sectors. The market is anticipated to expand at a CAGR of 19.88% during the forecast period, reaching an estimated value of
Global Bioregenerative Aesthetic Injectables Market Set for Strong Growth During 2026-2034 | AbbVie Inc., Croma-Pharma GmbH, Hugel, Inc.
Global Bioregenerative Aesthetic Injectables Market Set for Strong Growth During …
Polaris Market Research recently introduced the latest update on Bioregenerative Aesthetic Injectables Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous analysis of the Bioregenerative Aesthetic Injectables Market size, share, demand, key growth factors, segmentation, country-level overview, and forecast. The report helps businesses get a thorough understanding of the
Copper Mining Market Projected to Reach USD 235.28 Billion by 2034, Growing at a 2.29% CAGR from 2026 to 2034
Copper Mining Market Projected to Reach USD 235.28 Billion by 2034, Growing at a …
Global Copper Mining Market is currently valued at USD 191.96 Billion in 2025 and is anticipated to generate an estimated revenue of USD 235.28 Billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 2.29% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2026 - 2034 Polaris Market Research has introduced the latest market research report titled Copper
Specialty Oilfield Chemicals Market Projected to Reach USD 16.7 Billion by 2034, Expanding at a 4.9% CAGR from 2026 to 2034
Specialty Oilfield Chemicals Market Projected to Reach USD 16.7 Billion by 2034, …
Global Specialty Oilfield Chemicals Market is currently valued at USD 11.0 Billion in 2025 and is anticipated to generate an estimated revenue of USD 16.7 Billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 4.9% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2026 - 2034 Polaris Market Research has introduced the latest market research report titled

All 5 Releases


More Releases for Peptide

Peptide Express Launches Independently HPLC-Verified Research Peptide Catalog
Peptide Express has launched an expanded catalog of 30+ research-grade peptides, each independently tested by third-party laboratories for 99%+ purity. United States, 13th Jul 2026 - Peptide Express has announced the launch of its expanded catalog of research-grade peptides, built for laboratories, academic institutions, and independent researchers who require verifiable documentation of compound identity and purity. The platform gives researchers access to more than 30 research compounds, each independently tested by third-party
Peptide Dropshipping & White Label Peptide Fulfillment Solution Launch | RapidFu …
Image: https://www.globalnewslines.com/uploads/2026/04/a6b799d3d1fc2ae063a8a0793dc74785.jpg Los Angeles, CA - April 16, 2026 - RapidFulfillment.com, a leading 3PL fulfillment provider, today announced the launch of its Peptide Dropshipping Service Partnership, a turnkey white label peptide fulfillment solution designed to help entrepreneurs, eCommerce brands, and B2B operators enter the rapidly growing peptide market-without inventory, infrastructure, or operational complexity. This new service provides a fully integrated, end-to-end system combining U.S.-based peptide sourcing, compliant fulfillment, cold storage logistics, and
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be? In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights: • Global Peptide Cancer Drug Market Insight By Region & Indication • Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion • Approved Peptide Cancer Drugs: > 30 Drugs • Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis • Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase • Insight On Peptide Cancer Drugs In Clinical Trials: >
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established